Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases

Lipids

Volumn 36, Issue 6, 2001, Pages 629-636

  Ceruti, Maurizio ^a   Balliano, Gianni ^b   Rocco, Flavio ^b   Milla, Paola ^b   Arpicco, Silvia ^b   Cattel, Luigi ^b   Viola, Franca ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; DRUG PRODUCTS; SULFUR;

VINYL SULFIDE DERIVATIVES;

ENZYME INHIBITION;

22,23 EPOXY 2,10,15,19,23 PENTAMETHYL 6 (2 METHYLTHIOVINYL) 2,6,10,14,18 TETRACOSAPENTAENE; ENZYME INHIBITOR; OXIDOSQUALENE; SQUALENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; NONHUMAN; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION; SWINE;

EID: 0034894818     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0767-8     Document Type: Article

References (47)

1. The squalene-2,3-epoxide cyclase as a model for the development of new drugs
2. Enzymatic cyclization of squalene and oxidosqualene to sterols and triterpenes
3. Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae
4. Partial purification of 2,3-oxidosqualene-lanosterol cyclase from hog liver: Evidence of a functional thiol residue
5. Purification of 2,3-oxidosqualene cyclase from rat liver
6. Purification of the 2,3-oxidosqualene-Lanosterol Cyclase from Saccharomyces cerevisiae
7. Cloning and characterization of the 2,3-oxidosqualene-lanosterol cyclase-coding gene of Candida albicans
8. Nucleotide and deduced amino acid sequences of the oxidosqualene cyclase from Candida albicans
9. Sequence of the Candida albicans ERG7 gene
10. Specific amino acid repeat in squalene and oxidosqualene cyclases
11. Purification and properties of squalene-2,3-epoxide cyclase from pea seedlings
12. 13C NMR, crystallographic observations, and molecular mechanics calculations
13. Inhibition of 2,3-oxidosqualene cyclases
14. 2,3;18,19-Dioxidosqualene stereoisomers: Characterization and activity as inhibitors of purified pig liver 2,3-oxidosqualene-Lanosterol cyclase
15. Non-specific lanosterol and hopanoid biosynthesis by a cell-free system from the bacterium Methylococcus capsulatus
16. Hopanoids: The world's most abundant biomolecules?
17. Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase
18. Cloning, expression, and sequencing of squalene-hopene cyclase, a key enzyme in triterpenoid metabolism
19. Structure and function of a squalene cyclase
20. The possible role of a repetitive amino acid motif in evolution of triterpenoid cyclases
21. 29-Methylidene-2,3-oxidosqualene: A potent mechanism-based inactivator of oxidosqualene cyclase
22. Mechanism-based active site modification of oxidosqualene cyclase by tritium-labeled 18-thia-2,3-oxidosqualene
23. Studies of the substrate binding segments and catalytic action of lanosterol synthase. Affinity labeling with carbocations derived from mechanism-based analogs of 2,3-oxidosqualene and site-directed mutagenesis probes
24. Synthesis and biological activity of aza-squalenes, bis-azasqualenes and derivatives
25. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase
26. Inhibitors of 2,3-oxidosqualene cyclase as tools for studying the mechanism and function of the enzyme
27. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated substrate
28. Asymmetric synthesis of a mechanism-based inhibitor of oxidosqualene cyclase
29. Potency and inactivation rates of analogues of an irreversible inhibitor of vertebrate oxidosqualene cyclase
30. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase
31. Stereospecific syntheses of trans-vinyldioxidosqualene and β-hydroxysulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors
32. Synthesis of (6E)-8-thia- and (14E)-13-thia-2,3-oxidosqualene: Inhibitors of 2,3-oxidosqualene-lanosterol cyclase
33. Synthesis of sulfur- and sulfoxide substituted 2,3-oxidosqualenes and their evaluation as inhibitors of 2,3-oxidosqualene lanosterol cyclase
34. Synthesis of vinyl sulfide analogs of 2,3-oxidosqualene and their inhibition of 2,3-oxidosqualene lanosterol cyclase
35. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene lanosterol cyclase
36. Mechanism-based inhibitors and other active-site targeted inhibitors of oxidosqualene cyclase and squalene cyclase
37. Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase
38. 2,3-Oxidosqualene cyclase: From azasqualenes to new site-directed inhibitors
39. New synthetic applications of 1,3-benzodithiolium cations: Synthesis of aldehydes by 1-carbon homologation of carbonyl compounds
40. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives
41. Enzymes of sterol biosynthesis in liver and intermediates of sterol biosynthesis
42. Non-specific biosynthesis of hopane triterpenes by a cell-free system from Acetobacter pasteurianum
43. Non-specific biosynthesis of gammacerane derivatives by a cell-free system from the protozoon tetrahymena pyriformis
44. Stability of α-sulphur- and α-oxygen-substituted carbonium ions
45. Silicon-containing carbanions. II. Ketene thioacetal synthesis via 2-lithio-2-trimethylsilyl-1,3-dithiane
46. Identification and characterization of major lipid particle proteins of the yeast Saccharomyces cerevisiae
47. Cyclization of (3S)-29-methylidene-2,3-oxidosqualene by bacterial squalene-hopene cyclase: Irreversible inactivation and isolation of an unnatural dammarenoid